Oryon Cell Therapies
PrivateLast Round
Series A
Mar 23, 2026
Total Funding Raised
$42M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Oryon Cell Therapies is a biotechnology company that develops autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oryon Cell Therapies Comparables
Compare Oryon Cell Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspen Neuroscience | 88% | |
| Shanghai UniXell Biotechnology | 88% | |
| Kenai Therapeutics | 86% | |
Oryon Cell Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2026 |
Key People
Founding team and executive leadership
Oryon Cell Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Byers Capital | Series A |
| Neuro.VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
$21M round completed.
Oryon Cell Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oryon Cell Therapies's valuation, stock price, and market status.